Wall Street expects a year-over-year decline in earnings on higher revenues when Mirion Technologies, Inc. (MIR) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released o ...

Technologies, Inc. (NYSE:MIR) is one of the 11 Best Stocks to Buy for Investment. Over the past year, as of January 27, Mirion Technologies, Inc. (NYSE:MIR) shares have soared over 73%. Of the 9 analysts covering MIR, 89% rate the stock a Buy, while 11% rate it a Hold. MIR has a median price target of $29, which implies an upside potential of almost 14%. On January 23, TheFly reported that Morgan Stanley initiated coverage of Mirion Technologies, Inc. (NYSE:MIR) with an Equal Weight rating, setting the p ...

Core Insights - U.S. stocks experienced an upward trend, with the Dow Jones index increasing by approximately 200 points on Friday [1] Company Highlights - CG Oncology Inc (NASDAQ:CGON) saw its shares rise by 21.8% to $51.05 after announcing an expedited timeline for topline data from the Phase 3 PIVOT-006 clinical trial, now expected in the first half of 2026 [1][2] - Rich Sparkle Holdings Ltd (NASDAQ:ANPA) surged 113.6% to $51.70 following a $39 million offering of 3 million ordinary shares at $13 per share [3] - NovaBay Pharmaceuticals Inc (NYSE:NBY) increased by 34.4% to $12.81 [3] - Quanterix Corp (NASDAQ:QTRX) gained 29.3% to $8.42 after naming Everett Cunningham as President and CEO, effective January 19 [3] - MoonLake Immunotherapeutics (NASDAQ:MLTX) rose 21.7% to $17.45 after receiving FDA feedback on its clinical evidence strategy for Sonelokimab in Hidradenitis Suppurativa [3] - Enliven Therapeutics Inc (NASDAQ:ELVN) increased by 21.5% to $28.24, sharing positive initial data from its Phase 1b ENABLE trial for ELVN-001 in chronic myeloid leukemia [3] - Aeva Technologies Inc (NASDAQ:AEVA) surged 21.2% to $20.47 [3] - Loandepot Inc (NYSE:LDI) rose 20.1% to $2.93 [3] - ASP Isotopes Inc (NASDAQ:ASPI) increased by 19.7% to $7.71 [3] - Allogene Therapeutics Inc (NASDAQ:ALLO) gained 19.5% to $1.78 [3] - Opendoor Technologies Inc (NASDAQ:OPEN) rose 19.2% to $7.67 following a new housing market proposal by President Donald Trump [3] - Liquidia Corp (NASDAQ:LQDA) jumped 14% to $36.22 after announcing preliminary full-year 2025 YUTREPIA net sales [3] - Vistra Corp (NYSE:VST) gained 13.1% to $170.34 after entering into 20-year power purchase agreements for zero-carbon nuclear energy to support Meta's operations [3] - Oklo Inc (NYSE:OKLO) rose 12.6% to $109.95 after announcing an agreement with Meta for a 1.2 gigawatt power campus [3] - Applied Digital Corp (NASDAQ:APLD) surged 11.8% to $35.72, reporting strong second-quarter results and advanced talks with a new hyperscaler tenant [3] - AST SpaceMobile Inc (NASDAQ:ASTS) gained 10% to $99.65 [3] - SanDisk Corp (NASDAQ:SNDK) increased by 9.6% to $366.93 [3] - Mirion Technologies Inc (NYSE:MIR) rose 9.5% to $26.56 [3] - TTM Technologies Inc (NASDAQ:TTMI) gained 9.1% to $72.94 [3] - SoundHound AI Inc (NASDAQ:SOUN) rose 8.5% to $11.96 [3] - Kratos Defense & Security Solutions Inc (NASDAQ:KTOS) gained 8.3% to $112.64, with B. Riley Securities maintaining a Buy rating and raising the price target from $105 to $128 [3]

Core Insights - TimesSquare Capital Management's "U.S. Small Cap Growth Strategy" reported a gross return of 2.26% and a net return of 2.01% for Q3 2025, significantly underperforming the Russell 2000 Growth Index, which returned 12.19% during the same period [1] - The fund's top five holdings include Mirion Technologies, Inc., which has shown a 44.66% increase in share value over the last 52 weeks [2] Company Overview - Mirion Technologies, Inc. specializes in radiation detection, measurement, analysis, and monitoring products, serving the Medical and Nuclear & Safety segments [2][3] - The company’s nuclear power solutions are utilized in over 95% of the world's nuclear reactors, while its medical products are present in 80% of the world's cancer centers [3] Financial Performance - In Q3 2025, Mirion Technologies reported revenue of $223 million, reflecting a year-over-year increase of nearly 8% [4] - As of January 5, 2026, Mirion's stock closed at $24.65 per share, with a market capitalization of $6.024 billion [2] Strategic Developments - Mirion Technologies recently acquired Paragon Energy Solutions, enhancing its safety-related offerings for nuclear power plants and increasing its relevance in the small modular reactor (SMR) market [3] - The company is not among the top 30 most popular stocks among hedge funds, with 44 hedge fund portfolios holding its shares at the end of Q3 2025, down from 46 in the previous quarter [4]

Company Overview - Mirion Technologies, Inc. is a global leader in radiation detection, monitoring, and safety solutions, with core operations in nuclear energy and medical radiation [2] - The company provides critical instruments and calibration services essential for regulatory compliance and operational safety in nuclear plants, research facilities, defense programs, and hospitals [2] Revenue Model - Approximately 70% of Mirion's revenue is recurring, supported by long-term service contracts that renew automatically over the lifespan of reactors and medical systems, often lasting 40–80 years [3] - The nuclear and safety division accounts for about two-thirds of revenue and is poised to benefit from the global nuclear renaissance, with plans to triple reactor capacity by 2050 [3] Market Position and Growth Potential - Every new build, restart, or extension in the nuclear sector necessitates Mirion's radiation measurement systems, embedding its products in regulatory frameworks globally [4] - The medical division enhances stability by providing essential tools for radiotherapy quality assurance and dosimetry critical to cancer care and diagnostic imaging [4] Financial Outlook - Management targets 6–8% organic growth, approximately 30% EBITDA margins, and leverage below 3× within five years, potentially tripling free cash flow to $200 million [5] - Despite heavy amortization and integration costs obscuring true profitability, Mirion's systemic role in nuclear and medical sectors positions it for a re-rating as investors recognize its durable cash flow and intrinsic stability [5] Investment Thesis - Mirion Technologies is viewed as mispriced, being perceived as a legacy roll-up rather than a maturing compounder with high switching costs and regulatory entrenchment [4] - The company is considered a compelling long-term investment opportunity in the nuclear and medical safety ecosystem, especially as nuclear and medical tailwinds strengthen [5]

Core Insights - Windjammer Capital Investors has completed the sale of Paragon Energy Solutions to Mirion Technologies, indicating a strategic move in the nuclear power solutions sector [1][3]. Company Overview - Paragon Energy Solutions, based in Fort Worth, Texas, specializes in engineered solutions for large-scale nuclear power plants and small modular reactors (SMRs), providing essential products for safe operations in compliance with regulatory standards [2]. Investment Strategy - Since acquiring Paragon in November 2021, Windjammer has focused on strategic priorities such as enhancing sales channels, expanding product offerings, and developing new products for SMRs, which has contributed to significant growth and positioned Paragon for long-term success in the nuclear sector [3][4]. Management Perspective - Windjammer's Managing Director emphasized the partnership-driven investment approach, aligning with Paragon's management to expand its market reach and advance technologies for SMRs, showcasing Paragon's engineering capabilities and commitment to innovation [4][5]. Market Position - Paragon is recognized as a mission-critical and highly technical business, well-positioned to lead in the evolving nuclear solutions industry, capitalizing on the increasing demand for next-generation nuclear technologies [5].

Core Viewpoint - Mirion has successfully completed the acquisition of Paragon Energy Solutions, enhancing its capabilities in the nuclear power industry [1] Group 1: Acquisition Details - The acquisition integrates Paragon's engineering capabilities specifically tailored for the nuclear power sector [1]

Company Overview - JBT Marel (JBTM) is a member of the Business Services group, which consists of 259 companies and currently ranks 5 in the Zacks Sector Rank [2] - JBT Marel has a Zacks Rank of 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3] Performance Analysis - JBT Marel has gained approximately 9.4% year-to-date, outperforming the Business Services sector, which has returned an average of -12.3% [4] - In comparison, Mirion Technologies, Inc. (MIR) has seen a significant increase of 42.9% year-to-date, also holding a Zacks Rank of 2 (Buy) [4][5] Industry Context - JBT Marel is part of the Technology Services industry, which includes 124 companies and currently ranks 69 in the Zacks Industry Rank [6] - The Technology Services industry has an average gain of 11.5% year-to-date, indicating that JBT Marel is slightly underperforming its industry [6] Analyst Sentiment - The Zacks Consensus Estimate for JBT Marel's full-year earnings has increased by 7.8% over the past quarter, reflecting improved analyst sentiment and a stronger earnings outlook [3]

Summary of SMid Cap Industrials Conference Call Industry Overview - **Industry Focus**: North America Small and Mid Cap Industrials, particularly in AI infrastructure and related sectors [1][3][4] - **Key Themes**: - Market penetration within untapped Total Addressable Market (TAM) - Broad infrastructure investments - Nuclear power growth and safety - Electrification and automation trends [4][9] Company Insights APi Group (APG) - **Rating**: Overweight - **Current Price**: $37.4 - **Price Target**: $42 (12.1% upside) - **Market Cap**: $15.563 billion - **P/E Ratio**: 30.4x - **Revenue Growth CAGR**: 8% [3][6] Mirion Technologies (MIR) - **Rating**: Overweight - **Current Price**: $24.0 - **Price Target**: $34 (41.5% upside) - **Market Cap**: $5.955 billion - **P/E Ratio**: 57.3x - **Revenue Growth CAGR**: 2% [3][10] Rollins Inc. (ROL) - **Rating**: Overweight - **Current Price**: $59.4 - **Price Target**: $70 (17.9% upside) - **Market Cap**: $28.763 billion - **P/E Ratio**: 59.2x - **Revenue Growth CAGR**: 25% [3][6] Valmont Industries (VMI) - **Rating**: Overweight - **Current Price**: $391.2 - **Price Target**: $480 (22.7% upside) - **Market Cap**: $7.706 billion - **P/E Ratio**: 22.5x - **Revenue Growth CAGR**: 13% [3][13] Gates Industrial Corp (GTES) - **Rating**: Overweight - **Current Price**: $21.5 - **Price Target**: $33 (53.2% upside) - **Market Cap**: $5.563 billion - **P/E Ratio**: 15.5x - **Revenue Growth CAGR**: 7% [3][6] Regal Rexnord (RRX) - **Rating**: Overweight - **Current Price**: $131.0 - **Price Target**: $190 (45.0% upside) - **Market Cap**: $8.696 billion - **P/E Ratio**: 14.4x - **Revenue Growth CAGR**: 5% [3][6] Key Industry Trends - **Data Center Demand**: Expected electricity consumption from data centers to reach ~1,100 TWh by 2028, with a power installed base growing to 242GW by 2028 [22][24] - **Capex Growth**: Anticipated ~55% increase in annual grid investments from 2024 to 2030, driven by rising power consumption and infrastructure needs [31][32] - **Nuclear Power**: Significant partnerships with hyperscalers for nuclear energy supply, indicating a shift towards sustainable energy sources [37][45] Competitive Landscape - **Mirion Technologies**: Leading in nuclear safety technologies with a strong market share in 17 of 19 markets served, focusing on radiation safety and medical applications [52][54] - **Valmont Industries**: Positioned as a global leader in irrigation equipment and infrastructure solutions, benefiting from utility and telecommunications demand [91][96] Financial Metrics - **Average P/E Ratio**: 26.4x across covered companies - **Average Revenue Growth CAGR**: 14% for the sector [3][6] Conclusion - The SMid Cap Industrials sector is poised for growth driven by infrastructure investments, data center demand, and nuclear energy partnerships. Companies like Mirion and Valmont are well-positioned to capitalize on these trends, with strong financial metrics and growth potential.

Industry Overview - The artificial intelligence (AI) sector, bolstered by the growth of cloud computing and data centers, is experiencing a robust demand scenario, with a significant surge in data center capacity needed to manage and store cloud-based data [1] - AI infrastructure capital expenditure (capex) is projected to exceed $1 trillion by 2028 according to Goldman Sachs and Bank of America, while JP Morgan and Citigroup forecast a cumulative total of $5 trillion by 2030. McKinsey & Co. estimates that global AI-powered data center infrastructure capex will reach around $7 trillion by 2030 [2] Company Recommendations - Investors are advised to buy and hold five non-technology U.S. companies that are expected to benefit from the AI-driven data center boom in 2026. These companies have shown significant stock performance in 2025 [3] - The recommended companies include Comfort Systems USA Inc. (FIX), Vertiv Holdings Co. (VRT), Mirion Technologies Inc. (MIR), BWX Technologies Inc. (BWXT), and EMCOR Group Inc. (EME), all of which currently hold a Zacks Rank of 1 (Strong Buy) or 2 (Buy) [4] Company Insights Comfort Systems USA Inc. (FIX) - FIX operates primarily in the HVAC markets and is experiencing increased demand for specialized HVAC solutions due to the data center boom driven by AI and cloud computing [7][8] - The company is expanding its data center construction work, which is becoming a significant growth driver and attracting M&A activity [10] - Expected revenue and earnings growth rates for FIX are 14.7% and 16.4%, respectively, for the next year, with a 20.1% improvement in the Zacks Consensus Estimate for next year's earnings over the last 30 days [11] Vertiv Holdings Co. (VRT) - VRT is a leading provider of critical digital infrastructure for data centers and is benefiting from strong market demand and an extensive product portfolio [12][13] - The company is strategically expanding its capacity to meet the growing demand for AI-enabled solutions and has made acquisitions to enhance its service capabilities [13][14] - Expected revenue and earnings growth rates for VRT are 20.7% and 26.3%, respectively, for the next year, with a 6.8% improvement in the Zacks Consensus Estimate for next year's earnings over the last 30 days [15] Mirion Technologies Inc. (MIR) - MIR provides radiation detection and monitoring products and is focused on expanding its reach in the nuclear energy sector [16] - The company is integrating digital technologies into its radiation safety solutions and has recently partnered with Westinghouse Electric Company [17] - Expected revenue and earnings growth rates for MIR are 24.7% and 26.5%, respectively, for the next year, with a 1.6% improvement in the Zacks Consensus Estimate for next year's earnings over the last 30 days [18] BWX Technologies Inc. (BWXT) - BWXT manufactures nuclear components and is benefiting from strong bookings and government contracts, particularly in the nuclear sector [19][20] - The company's total backlog reached $7.4 billion, up 119% year over year, driven by robust federal demand and a growing pipeline [21] - Expected revenue and earnings growth rates for BWXT are 14.5% and 9.9%, respectively, for the next year, with a 0.2% improvement in the Zacks Consensus Estimate for next year's earnings over the last seven days [24] EMCOR Group Inc. (EME) - EME is a leading provider of critical infrastructure to AI-powered data centers, focusing on electrical infrastructure and cooling systems [25] - The company is gaining traction in the data center construction market, which is contributing to its expanding performance obligations [26][27] - Expected revenue and earnings growth rates for EME are 5.9% and 8.6%, respectively, for the next year, with a 1.2% improvement in the Zacks Consensus Estimate for next year's earnings over the last 30 days [28]